首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review

【2h】

Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review

机译：培加他尼和兰尼单抗治疗新生血管性年龄相关性黄斑变性：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo assess the clinical effectiveness of pegaptanib sodium and ranibizumab for neovascular age‐related macular degeneration (AMD).

机译：目的评估培加他尼钠和兰尼单抗治疗新生血管性年龄相关性黄斑变性（AMD）的临床效果。

著录项

期刊名称 The British Journal of Ophthalmology
作者
A L Takeda; J Colquitt; A J Clegg; J Jones;
展开▼
作者单位

展开▼
年(卷),期 2007(91),9
年度 2007
页码 1177–1182
总页数 6
原文格式 PDF
正文语种
中图分类眼科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. [J] . Takeda AL, Colquitt J, Clegg AJ, British journal of ophthalmology . 2007 ,第9期

机译：培加他尼和兰尼单抗治疗新生血管性年龄相关性黄斑变性：系统评价。
2. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. [J] . Colquitt JL, Jones J, Tan SC, Health technology assessment: HTA . 2008 ,第16期

机译：雷尼单抗和培加他尼用于治疗年龄相关性黄斑变性：系统评价和经济评价。
3. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation [J] . Health technology assessment: HTA . 2008 ,第16期

机译：雷尼单抗和培加他尼治疗老年性黄斑变性：系统评价和经济评价
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Comparative Safety of Bevacizumab Ranibizumab and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies [O] . Anna A. Plyukhova, Maria V. Budzinskaya, Kirill M. Starostin, 2020

机译：贝伐单抗雷珠单抗和阿柏西普治疗新血管性年龄相关性黄斑变性（AMD）的比较安全性：直接比较研究的系统评价和网络Meta分析
7. Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review [O] . Takeda, A L, Colquitt, J, Clegg, A J, 2007

机译：培加他尼和兰尼单抗治疗新生血管性年龄相关性黄斑变性：系统评价

Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review

摘要

著录项

相似文献

相关主题

期刊订阅